Advanced pharmacy services as part of a CPA are described as collaborative management of drug therapy (CDTM). [a] While traditional practice for pharmacists provides that the legal authority recognizes drug-related problems (DOP) and proposes solutions for PDs to prescription persons (e.g. B physicians), pharmacists who offer CDTMs solve PDs directly when they recognize them. This may include prescribing drugs to select and initiate drugs to treat a patient`s diagnosed illnesses (as described in the CPA), stopping the use of prescription or over-the-counter drugs, and modifying a patient`s drug treatment (for example. B change in strength, frequency, frequency of administration or duration of therapy), evaluation of a patient`s response to drug treatment (including drug treatment). , such as.B. a basic metabolic panel) and the continuation of drug therapy (with a new prescription). [7] A Collaborative Practice Agreement (CPA) is a legal document in the United States that establishes a legal relationship between clinical pharmacists and cooperating physicians, allowing pharmacists to participate in collaborative therapy management (CDTM). Another important change to SDCL 36-9A is the removal of joint regulation of CNPs and NCMs by the Board of Medical and Osteopathic Examiners and the Board of Nursing. The regulation of NPCs and NMCs is provided exclusively by the Board of Care.
This is part of the regulation of advanced nurse practitioners across the country. Fewer than five states have this common regulatory model. The first step to ensuring that NPs are fully in authority across the country is to understand the current practical contexts of the state. The American Association of Nurse Practitioners (AANP 2017) defines three practical statutes at the federal level: CPAs are a priority for lobbying for professional pharmaceutical companies. In January 2012, the American Pharmacists Association (APhA) brought together a consortium of pharmacy, medical and care professionals from 12 countries to discuss the integration of CPAs into daily clinical practice. [53] The consortium published a white paper entitled “Consortium Recommendations for Advancing Pharmacists” Patients Care Services and Collaborative Practice Agreements and summarized their recommendations. [18] One of the most significant changes removes the requirement that CNP and CNM must have a written cooperation agreement with a physician to fully practice. These include conducting advanced assessments and evaluations, prescribing treatments and medications, ordering diagnostic tests and signing official documents.